Select Medical Q4 Earnings Miss Estimates, Stock Down 7.2%
Portfolio Pulse from
Select Medical's Q4 earnings missed estimates, leading to a 7.2% drop in stock price. The company projects 2024 revenues between $5.4 billion and $5.6 billion, indicating a 5.8% growth from 2024's $5.2 billion.
February 24, 2025 | 6:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Select Medical's Q4 earnings miss led to a 7.2% stock decline. Despite this, the company forecasts a 5.8% revenue growth for 2024.
The earnings miss directly impacted SEM's stock price, causing a significant drop. However, the revenue growth forecast for 2024 provides a positive outlook, though it may not immediately offset the negative sentiment from the earnings miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100